Tell everyone a little about yourself and what you hope to gain from the Global Ethics Network.
We are the 2017 Taipei American School iGEM Team. iGEM (International Genetically Engineered Machines) is an international genetic engineering competition that is open to both undergraduate and high school students interested in the field of synthetic biology. Our project is focused on cleaning up nanoparticle waste in wastewater treatment systems, and as a part of our Human Practice component for the tournament, we aim to explore key topics in bioethics. Specifically, we are interested in existing international chemical substance regulations, ethics concerns consumers may have, and how governments and industries can collaborate in implementing new technologies (such as nanoparticles). Through this forum, we hope to receive a diversity of opinions and perspectives on this issue to provide us with further insight. Our goal is to produce a policy paper that aims to regulate nanoparticle usage, address the disparity between emerging technologies and international law, and address bioethics concerns related to not only our prototype but to nanoparticles in general as well.
I picked interest on you after going through your short profile and demand it necessary to write you immediately. I have something very vital to disclose to you, but I found it difficult to express myself here, since it's a public site.Could you please get back to me on (email@example.com ) for the full details.
Jeffrey Kahn, director of the Johns Hopkins Berman Institute for Bioethics, discusses the many governance issues connected to gene editing. Plus, he gives a first-hand account of an historic conference in Hong Kong last year in which Dr. He Jiankui shared his research on the birth of the world's first germline genetically engineered babies. What's the future of the governance of this emerging technology?
Astute observers of U.S. foreign policy have been making the case, as we move into the 2020 elections, not to see the interruptions in the flow of U.S. foreign policy solely as a result of the personality and foibles of the current occupant of 1600 Pennsylvania Avenue, writes Senior Fellow Nikolas Gvosdev. Ian Bremmer and Colin Dueck expand on this thought.
In the first in a series of podcasts on gene editing, Columbia's Dr. Robert Klitzman provides an overview of the technology, ethical and governance issues, and where it could all go in the near future. Plus he explains why the birth of genetically engineered twins in China last year was a "seismic" event. How could gene editing lead to more inequality? What could be some of unintended consequences?
The views and opinions expressed in the media, comments, or publications on this website are those of the speakers or authors and do not necessarily reflect or represent the views and opinions held by Carnegie Council.